Brief: GeneDx Q4 Revenue Of $61.4 Million
14/03/2023 21:01
Mar 14 (Reuters) - GeneDx Q4 adjusted gross margin 7%. * Q4 REVENUE USD 61.4 MILLION * Q4 GROSS MARGIN -27%
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth